Vaccines cannot be treated like a commodity

Massive public investment has gone into developed Covid-19 vaccines, and patents on vaccines must be waived to ensure they are not treated like a commodity, says Visiting Policy Fellow Els Torreele (UCL Institute for Innovation & Public Purpose).

Listen: BBC World Service’s ‘Business Daily’ (from 6 mins 20 secs), More: Hindustan Times (India)